Intrinsic Value of S&P & Nasdaq Contact Us

G1 Therapeutics, Inc. GTHX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
33/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.50
-37.2%

G1 Therapeutics, Inc. (GTHX) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 9 Buy, 1 Hold, 1 Sell.

The consensus price target is $4.50 (low: $3.00, high: $6.00), representing a downside of 37.2% from the current price $7.16.

GTHX Stock — 12-Month Price Forecast

$4.50
▼ -37.15% Downside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for G1 Therapeutics, Inc., the average price target is $4.50, with a high forecast of $6.00, and a low forecast of $3.00.
The average price target represents a -37.15% change from the last price of $7.16.
Highest Price Target
$6.00
Average Price Target
$4.50
Lowest Price Target
$3.00

GTHX Analyst Ratings

Buy
11
Ratings
9 Buy
1 Hold
1 Sell
Based on 11 analysts giving stock ratings to G1 Therapeutics, Inc. in the past 3 months
Rating breakdown
Buy
9 82%
Hold
1 9%
Sell
1 9%
82%
Buy
9 analysts
9%
Hold
1 analysts
9%
Sell
1 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message